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Summary 
Two cases of Wilson's disease occur-
ring in ,the Maltese Islands are described 
and their response to Penicillamine thera-
py together with various aspects of Peni-
cillamine therapy discussed. The first case 
is particularly inter,esting as dramatic cli-
nical recovery occurred in spite of seven 
years of complete incapacity from the dis-
ease, implying that the neurological dis-
turbance in Wilson's disease is always 
potentially reversible, however severe the 
degree and prolonged the duration of the 
initial incapacity before therapy is started. 
The ,term hepato-lenuicular degenera-
tion, as a synonym for W,Hson's disease 
was coined by Hall 'in 1921, ten years after 
the ~pooh making description of the di-
sease by Kinnier WiIson. Though the ex-
cess of copper in the liver of these patients 
had been noted as early as 1913 by Rum-
pel, this worker was more impressed by 
the amount of sdlver in the tissues. It was 
Cumings who in 1948 estahlished beyond 
doubt the presence and importance of .ab-
norma,l copper metaboli:sm in this illness. 
The di:sease has been regarded as being 
excessively rare but with the discovery 
of many new cases, the incidence 'is now 
known to be much higher than had pre-
viously been calculated. Two paitients 
are described below and observations are 
made on the prevalence of the disease in 
the Maltese Islands, and on the effect of 
treatment on ,the disease. The case of the 
first patient described is particularly in-
teresNng because in spite of the long dura-
tion of seven years of tota>! incapacity 
before Penicillamine therapy was sltarted, 
the degree of clinical recovery has been 
remarkable. 
Cas,e 1 
L.S., an unmarried female of 32, and 
one of the offspring of a first cousin 
marriage was first seen at home in March 
1965. She g,ave a history of seven years 
total physical incapacity :resulting from 
very gross involuntary movements affect-
ing the limbs and trunk. 
Her illness had ,stanted at the age of 
18. The first :symptom noted was that of 
tremor affecting the right hand, develop-
ing one night when she was on night duty 
as la nurse at a loca'l hospital. The tremor 
was aggravated by ,intentional movements 
and became rapidly worse in the next few 
weeks, duning which time her left hand 
also began to tremble. The tremor was 
coarse in nature. Coarse involuntary 
movements soon laffected the trunk and 
lower limbs and within six months of the 
onset of her illness Ishe had become com-
pletely bedridden as the slightest attempt 
at purposeful vO'luntary movement resul-
ted in gross accentuation of the violent 
tremor. Feeding and drinking without 
help became impossible. Her mental fa-
culties did not appear to be affected and 
she showed no emotional labiHty. Her 
general condition had remained static 
through all the lintervening years. She 
claimed that early in the course of her HI-
ness marked photophobia was present as 
was contim:ous pain in the cubital and 
popliteal fossae. She had been seen over 
the years by various doctors and various 
remedies had been prescribed. Even 
hypnosis had been tried after the ddagno-
sis of hysteria had been made by .a spe-
cialist. 
Her past medical his,tory was unre-
markable. She had suffered from the 
usual childhood illnesses. There had 
never been any liver disorder or h1story 
of haematologicaI trouble. 
Family history 
Her mother was in good health. Her 
fa,ther had diabetes mellitus and had suf-
fered from jaundice as a young man. A 
ten-year o:ld hrother of the patient had 
died in hospital because of haemolytic 
anaemia of unknown cause. An elder 
sister was alive and apparently normal 
while another brother was still alive 
though mentaNy retarded. 
On examinatlion, .the patient appeared 
well built and obese and showed oonstant 
violent shaking of the limbs and tmnk. 
Her heart rhythm was normal and her 
blood pressure wa,s 150/90. The patient 
was very cooperative and appeared of 
normal intelligence and not confused. No 
hepatomegaly or splenomegaly could be 
elicited. On examination of her central 
nervous system, very prominent Kayser 
Fleisher rdngs in both eyes were present. 
There were no othe,r cranial nerve abnor-
malities. She talked in a very staccato 
manner. TitUlbation of the head was 
severe. Very gross static and intention 





both upper l'imbs was seen. Moderate 
cogwheel rigidity at the elbows and wrists 
oould be felt. Violent involuntary move-
ments were also present in the lower 
limbs ,as was modeirate cogwheel rigidity. 
Tendon reflexes were exaggerated !in aU 
four limbs. Both plantar responses were 
flexor. There was no obvious weakness 
in the Limbs and it was apparent that 
physica:l incapacity was totally related to 
the gross tremor. No abnormalities of her 
sensory modalities could be demonstrated. 
The patient could only stand up with the 
greatest difficulty because of lurching 
from the severe tremor. Physical exa-
mination showed no other abnorma'I,1ties. 
Breasts were normally developed. No 
abnormalities of the nail beds were seen. 
Investigations included: Hb. 14.5g/100 
ml.; RBC 5,190,000/c.mm.; platelets 
58,OOO/c.mm.; blood film: no abnormality; 
blood urea 32 mgm%. Her serum biliru-
bin was 1.1mgm/100ml.; the van den 
Bergh reaction was indi:rect; SGPT: 
171.U./
'
ldtre; serum alkaline phosphatase 
9 units/lOOml. The serum ca.Jcium level 
was 5.5 mEq. / litre; plasma ,inorganic 
phospate 2.3mgm./100ml. Serum mic 
acid wa;s 4.2mgm/100 ml. 'Dhe prothrom-
bin time was 1'8 seconds (control 15 secs.). 
The Ooombs test was negative. The 
RPCF, Wassermann and Kahn tests were 
negatJive. Serum protein electrophoresis 
showed the follow:ing percentages: albu-




24 hour urinary excretion of glucose 
was 0 g., while that of uric acid was 1.42g. 
X-rays of the knees and elbows showed 
no abnormalities. Serum copper and se-
rum caeruloplasmin levels were not per-
formed at the time for technical reasons 
though later figures (see below) are avai-
lable. 
On 22.4.65, the patient was started 
on D-Penicillam:ne in a dose of 300mgm. 
four times daily. On 1.5.65, the patient 
developed a temperature of 102°F and a 
severe generalised urticarial rash. Peni-
cillamine was stopped the next day and 
Benadyrl 25 mgm. twice daily given. The 
rash and temperature subsided after three 
days and on 7.5.65, Penicillamine was re-
sta:-:ted in a dose of one capsule (l50mgm.) 
daily. As there was no recurrence of 
temperature and -rash and no evidence of 
other toxic side effect, PenicHlamine was 
gradually increased in dose every few few 
days till she was having 8 capsules daily 
(1200 mgm,) by the 29.5.65. Penieilla-
mine was increased to 10 tablets daily 
(1500 mgm.) on 16.6.68 and this dose was 
adhered to, over the next few months. 
The parent was kept in hospital under 
observation till 29.6.65, when she was dis-
charged home with a view to reassessment 
afte:r a few months. At the time of her 
discharge, no evidence of cHnical improve-
ment could be detected, nor was there any 
fur-ther clinical deterioration. 
She was readm'tted on 20.9.65 for 
review. She now appeared clinicaNy 
much better. Ameliora tion of her symp-
toms had started c.bout three weeks be-
fore. The gmss ietention tremor of the 
upper limbs had diminished and she was 
now starting to wa.lk slowly and unaided 
for the first time ,in seven years. Ataxia, 
however, was still very evident. The 
severe dysarthria had also improved. A 
repeat blood count showed no change 
rupart from a rise in her platelet count to 
250,000 c.mm. Liver function tests 
showed a serum biHrubin of 0.9 mgm./ 
100 ml.; a SGPT of 15 r.U./Htre and a 
serum alkaline phosphatase of 18.7 K.A. 
un;ts/100ml. There was no proteinuria 
nor were there any renal casts. The re-
gime ofl200 mgm. of Penidllamine daily 
was continued. When reassessed again in 
January 1966 (eight months after start-
ing Penicillamine) the change in the cli-
nical picture was remarkable. Gait was 
now practically normal and the only 
noticeable abnormality was slight tituba-
tion of the head and trunk, ,and minimal 
intention tremor of the hands. She could 
now carry out all ordinary physical activi-
ties and household duties and often went 
out for long walks alone to neighbouring 
viNages. The Kayser Fleischer rings, 
though stiU present were far less evident. 
Her clinical condition over the last six 
years has shown further improvement. 
Tremor of the limbs is only intermittent 
and mild, and is only evident when she is 
excited. Her intellectual faculNes appear 
norma'! and there is no abnormality of 
affect. Her neurological functional distur-
bance is therefore now, according to the 
classification of Goldste~n and his col-
,leagues, (1962), Grade 1, whereas her 
former clinical grading according to the 
same system was Grade 4. 
She is at present on Penicillamine, 
1050 mgm. daily. She has been on Peni-
cillamine now for over seven years. 
On 8.6.68, the foNowing estimations 
were made: 
Serum Copper 46 ug/100 ml.(~" 
Caeruloplasm:n 5.87 mg/lO ml. 
Uninary Copper 87 ug/24 hrs. 
Case 2 
A 19 year old Maltese malle, J.C., 
was referred by his doctor for a second 
opinion, because of involuntary move-
ments, which were es'pecially noticeable 
when the patient became excited. The 
first symptoms had started ,about six 
months previously as the patient was 
voluntarily swaying his body whi1le Hsten-
ing to a favourite piece of "pop" -music. 
He found that he could not stop the 
rhythmic movements completely when the 
music record stopped. His doctor at first 
thought that the symptoms we,re purely 
psychologic'al and prescribed a small daily 
dose of phenobarbitone. A second opin:cm 
was sought, however, when the symptoms 
began to deteriorate :in spite of treatment. 
When seen as a hospital outpatient 
(22.3.67), the only abnormality detected 
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Family 2 
was the mild rhythmic movements of the 
trunk together with some head titubation. 
Only minimal static tremor of the out-
stretched arms could be detected. There 
was no ·intention tremor. ~he patient had 
no dysalrthria. A faint Kayser Fle1scher 
ring was bilaterally present. The cranial 
nerves were normal. T<he tendon reflexes 
were also normal and both plantar res-
ponses were flexor. There was no hepa-
tomEgaly or splenomegaly. The rest of 
physical examination was normal. 
Family History: 
He was the seventh offspring of a 
ncnconsanguinceus marriage. The second 
offspring - a male - had died at the age 
ef n:ne after developing jaundice and 
ascites as a complication of an obscure 
iiver disorder. 
He was admitted to hosp,ita'l for 
further inve: tigation. The presence of the 
~(ayser FIe:: sher rings was confirmed by 
slit lamp m:croscopy. The blood count 
W<1JS normal. The serum bHirubin Wias 
O.5mgm./l00ml.; the van den Bergh reac-
tion negative; serum GPT 10 LU.j:Iitre. 
The Bromsulphthalein test showed 43,% 
retention. Serum calcium was 5.5 mEq./ 
Ure; Plasma inorganic phosphate: 3.1 
mgm./IOOml. The serum uric acid was 
4.2mgm./IOOml. Urinary uric acid was 
0.44g. per 24 hrs. The tota'l serum pro-
teins were 7.8 g./IOO ml., of which 4.4g. 
were ,albumin. X-rays skull was normal 
as was a skeletal survey. 
There was a delay of four weeks in 
obtaining Penicillamine supplies for treat-
ment. Treatment was started with an 
initial dose of 1200mgm. D-Penicillamine 
daily. No toxic side effects were obser-
ved. During the week prior to Penidlla-
mine treatment, there was further notice-
able clinical deterioration. His ga'it be-
came ataxic for the first time and the head 
titubation worsened considerably. The 
first beneficial effects I( clinically) of Peni-
cillamine became obvious about eight 
weeks after the start of therapy. Gradual 
regression of his symptoms ,then began. 
At the present time all the abnormal 
neurologicall signs have disappeared, with 
the sole exception of the Kayser Fleischer 
rings, which are etill present though very 
faint. 
His neurologic<1J1 functional distur-
bance is therefore Grade 0 (Goldstein et al. 
1962), whereas the runctiona:l disturbance 
at the start of tre~tment was GnicIe l. 
The patient was at first on a main-
tenance dose of D-Penicillamine (1500 
mgm.) daily but the dose has ne w been 
curtailed to 900 mgm. daHy. He is com-
pletely symptom free. 
On 15.6.67, the following estlim3.,tions 
were made: 
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Serum Copper 76.1 ug/100 ml. 
Caeruloplasmin 14.1 mg/100 ml. 
Urinary Copper 104 ug/24 hrs. 
Discussion 
These cases rure the first reported 
cases occur:ring in the Maltese Islands. 
Though Wilson's disease has a wide geo-
graphic distribution and has been descri-
bed in individuals of many races and 
countries induding Negroes, Indians, 
Chinese, Ma,layans, Japanese and Es-
kimos (Boudin & Pepin, 1959; Cum-
ings, 1959), it has never been pre-
viously reported in Maltese patients. This 
is surprising because the region of Sicily 
and the extreme tip of Italy is held to be 
one of the geographical aieas in Europe 
where Wilson's disease occurs with un-
usually high incidence. Thus Bearn (1960) 
in his study of thirty famil<ies in New York 
City, in whom Wilson's disease had been 
discovered, found that seven of them ori-
ginated from Sicily and Southern Italy. 
Another area, where many cases of Wil-
son's disease have been found is Eastern 
Poland. It has been suggested thaot the 
originall mutat:ons in Eastern Poland and 
Sicily were not identical as the patients 
of Sioilian origin had an earl,ier age of 
onset, more severe symptoms, more 
hepatic involvement .and more abnormal-
ity of serum copper and caeruloplasmin 
levels. 
The relative severity of involvement 
'of the brain and liver in different families 
has also been interpreted as a further ,in-
dication of genetic heterogeneity in Wil-
son's disease and the family with three 
sibs showing severe liver cirrhosis with-
out neurological signs described Iby Fisher 
and Sherlock (1964) has been quoted in 
favour of this hypothesis. 
Considerable migration rinto Malta 
from Sicily has occurred over the centu-
ries and 'Lt is therefore reasonable to sup-
pose a priori, that a higher prevalence 
than usual (albeit undetected) of Wilson's 
disease exists rin the Ma1tese Islands. This 
is atll the more likely in view of increased 
incidence of consanguinity that exists in 
some of the more isolated areas of the 
Maltese Islands. 
The effect of increased consanguinity 
rate in geographical isolates has perhaps 
been best illustrated in the case of Wil-
son's disease in the Ards Peninsula of 
Northern Ireland where the gene carrier 
inoidence of this recessive disease has 
been estimated as approximately 1 in 40 
(Warnock, 1961). Other factors affecting 
the known prevalence of such a disease 
in a geographical region, are clinical dia-
gnostic awareness and the ava,illabilrity of 
specialised laboratory procedures in estab-
lishing the diagnosis. In places where labo-
ratory facilities a:re difficult, it ,is only 
possible to have an unconfirmed diagno-
sis if ,the disease presents in an unusual 
way and rH Kayser Fleischer rings are not 
present. A Kayser Fleischer ring is the 
only pathognomic sign of ,the disease and 
its demonstration ,obviates the need of 
laboratory procedures a,s the diagnosis of 
Wilson's disease can be made at the bed-
side outside hospital (Warnock, 1961). 
Two families have been discovered in 
Malta with affected individuals. Only two 
affected individua:ls are living a's the other 
two siblings strongly suspected of hav,ing 
had the undiagnosed disease died in late 
chHdhood a few years ago. One died of 
liver disease complicated by asdtes while 
the other died of acute haemolytic anae-
mia - again a well known form of pre-
sentation of Wilson's disease. 
The two affected individuals from 
different families presented with neurolo-
gical manifestations. It is interesting to 
note that the suspected siblings who died, 
had different types of the disease ,and 
are therefore exceptions to the 'generalisa-
tion that the disease ,in anyone s,ibship 
conforms to a distinctive clinical pattern. 
These findings cannot be held in favour 
of the different patterns of the disease 
depending on the geographical region 
where the ,individuals originate. One can 
only state that till analysis of large cli-
nical samples become avaIlable in due 
course, such views can only be regarded 
as conjectures. 
The prevalence of the disease in the 
Maltese ISllands is therefore about 1 ,in 
150,000 of the population. If the two dead 
siblings who ,in all probahility had 
undiagnosed Wilson's disease are a:lso in-
" 
cluded ,then the prevalence would be about 
1 in 75,000. 'Dhe true prevalence is most 
likely greater than this figure, and the next 
few years should uncover more cases. It 
is of interest that one patient is the off-
spr.ing of a first cous,in marriage whHe the 
parents of the othN family are totally 
unrelated. Bearn (1960) showed that the 
frequency of consanguineous matings 
(first and second cousins) among the pa-
rents .of thirty silbships with Wilson's dis-
ease was about 46%. It can be taken as 
an approximate rule that about ha1f the 
families with WUson's disease show evi-
dence of consanguinity. In 1961, Beam 
calculated that the overall gene frequency 
mte is of the order of 1 in 500, thus 
giving rise to, a disease incidence of 1 in 
1,000,000 'Of the population. In the last 
few years, because of the ,increasing focus-
sing of ,attention .on the disease and the 
discovery of many fresh cases, the report-
ed incidence has risen. Among the coun-
tries where a re'latively high incidence has 
been reported is Ruman~'a where it ,is noW 
about 1 in 100,000 (Kreindler, Ionescu, 
Drinca-Ionescu, 1964). 
Perhaps Qne of the most striking cli-
nical features in one of the patients des-
cribed above is ,the fact that there had 
been seven years' tota:l incapacity bef.ore 
treatment with Penkillamine was institut-
ed. The introduction of Penicillamine 
(b, b-dimethyl-cysteine hydrochloride) as 
a copper chelating agent in Wilson's dis-
ease by Walshe in 1956 ,is one of the most 
,tmportant landmarks in the history of the 
iUness. IIts beneficial effects have been 
increasingly recognised .over the past few 
few years and it is now the drug of choice. 
BAL, which was introduced by Cumings 
in 1948, has been mostly superseded 
though an authority such as Kelly (1958) 
feU that the clinical results obtai1ned after 
BAL therapy were superior to those of 
Penicillamine. It is well known that cases 
of Wilson's disease showing total disahle-
ment have recovered dramaticaUy after 
treatment with Penicillamine. Thus nine of 
a series of fourteen patients described by 
Walshe having neurological involvement 
and sh~wing severe or total disability, 
became virtually symptom free after two 
or three yea,rs of uninterrupted therapy. 
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What ,is most unusuail, however, is the 
dramatic extent of recovery after such a 
long time (seven years) .of total disability 
as demonstrated in the Maltese patient 
described. As far as can be ascertained, 
none of W,alshe's nine patients in that par-
ticular series, who made a good recovery 
had been totally disabled for such a long 
time. Walshe thought it problematical 
whether the patient he mentioned with a, 
twenty year history of ataxia would ever 
make a rea'lly useful recovery. 
Some indirect implica,tions therefore 
arise regarding the prognosis in treatment 
and also regarding the mechanism of c.op-
per deposition in the tissues. It has been 
established that excess copper is always 
associated with the development of cli-
nical symptoms in untreated cases though 
the time factors involved in the deposlition 
of copper are unknown. The exact mechan-
ism for copper deposition are moreover 
still a matter of controversy. Uzman's pos-
tulate (1957) of an abnorma;l protein with 
an undue affinity to copper as the essen-
tial defect in Wilson's disease is now con-
slidered untenable (Gibbs and Wa>ishe, 
1966). Bromall (1964) has put forward an 
almost opposite theory. He claims that it 
is the defiCiency of the transport protein 
caeruloplasmin serving as a carrier of a 
copper containing prosthetic group which 
leads to, brain damage. This prosthetic 
group normally acts as an oxygen activat-
ing unit in cytochrome c oxidase accord-
ing to Broman. In the case of the liver, 
damage is due to a direct toxic action of 
copper on the cells. Others hold that the 
brain damage results from an obscure form 
of liver dysfunction, as evidence .of micro-
scopical damage from copper deposition 
is more controversia'!. Up to the present 
time the exact ,role of the mysterious trans-
port protein caerulopJasmin in copper me-
tabolism is still unknown. 
The ,first patient mustrates the fact 
that even after seven years of functional 
incapacity from the disabling straight-
jacket of copper deposition, no irrever-
s~ble structural damage must of necessity 
be presumed. It is therefo:re essential to 
pursue full energetic treatment in spite of 
apparent ,initia'l lack of response for many 
months. The delay of several months 
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before clinical improvement is noticed 
after the sLut of Penicillam:ne may lead 
to d'scontinuation of the drug and its sub-
stitut:on by a ~ess satisfactory chelating 
agent such as BAL, if this delay in clini-
cal improvement is not fully appreciated 
by the cldnician. The first case desoribed 
above irllustrates this point. It is strongly 
suspected by the author that opinions ex-
pressed in the past by some workers in 
favour of BAL therapy as against Penicil-
lamine were based on inadequate duration 
of PeniciIlamine therapy. The delay in cli-
nica: improvement after the administra-
tion of Penicillamine, was also stressed 
by R:chmond, Rosenoer, Tompsett, Draper, 
and Simpson (1964). In Case 2 of the three 
cases they described, the drug was tem-
po~arily abandonec:l in favour of dimer-
caprol (BAL) because of the bel'ief that 
Pen;c;.llamine was not having any effect. 
In their first case, 'little change was seen 
fo:- ,,-bout two months. 
Another important facet shown by 
the first patient concerns the initial toxic 
side effects of Penicillamine that may 
occur, only a few days after the adminis-
tration of ,this drugs. These initial toxic 
reactions may trap the unwary physician 
into stopp,ing Penicillamine therapy per-
manently in such a patient .It is important 
to emphasise tha,t the duration of this drug 
reaction is only temporary. The first pa-
tient above described developed the drug 
skin rash about a week after the drug was 
started. This happening has also been pre-
Viiously reported in ,the literature. Thus, a 
skin rash developed on the 8th to 10th 
day of treatment in five out of sixteen 
patients treated for cystinuria, by MacDo-
nald and FeUers (1966). In three of these 
patients 'the drug was restarted in small 
doses ,after a week and inoreased gradual-
ly until the original dose was reached, no 
further complications occurring. Another 
method used ,in one of their patients was 
the administration of an initial dose of 
100mgms. of Cortisone acetate intramus-
cularly followed by 10mgms. of Predni-
sone daily for five days. The steroid dos-
age was then graduaJlly reduced during 
the following week. The development of 
this acute sensitivity reaction has been 
observed in about one third of patients 
treated with PenicTamine (Sternlieb and 
Scheinberg 1964). 
Other undesirable side-effects may 
arise through Penioillamine. OccaSionally, 
there may be a tr,ansient optic neuritis 
(Tu, Blackwell and Lee, 1963). The most 
serious reaction is the development of the 
nephrotic syndrome (Fellers and Shahidi, 
1959). Death may occasiona.Jly occur ('Io-
nis and Karp, 1963). Sternlieb holds the 
view that only patients receiving the race-
mic or DL form of Penicillamine develop 
this complication (Sternlkb, 1966), and 
that no cases have been recorded in pa-
tients receiving D-PenicHlamine which is 
the form commonly used nowadays. Ros-
enberg and Hayslett (1967) however re-
ported nephrotoxic effects with D-Pen:cH-
lamine in three pati'ents suffering from 
cystinuria. The toxic effects regressed 
three to six months after cessat'on of 
treatment; ,renal biopsies in each of their 
patients showed a distinct focal glomeru-
litis. 
There does not seem to be any marked 
anti-pyridoxine activity of D-PenioiUamine 
as has been reported .for L-Penicillamine 
(Kuschinskas and du Vigneaud, 1957). 
L-PenidEamine is a potent antagonist of 
pynidoxine combining with pyridoxal to 
form a thioxolidine. It is however advis-
able with prolonged admin:stration of the 
drug to add pyridoxine supplements. In 
case I, the complaint of aches and pains 
in the lower ext'remities together with a 
fee~ing of pins and needles promptly dis-
appeared with the exhib'tion of Pyridoxine 
20mgms three times daily. 
These observations on the toxioity of 
Penicillamine are all the more re'levant in 
view of the cont~oversial authoritative 
paper by Sternlieb and Scheinberg (1968), 
'backed by Walshe (1968) urging treatment 
of all asymptomatic subjects in whom a 
biochemical diagnos;s of Wilson's disease 
has been reached. 
A clinical feature common to the two 
pa,tients a:bove described is the rapid de-
terioration in neurolog:cal function, once 
symptoms had appeared. The first patient 
was completely incapacitated within six 
months of the onset of symptoms. The 
deterioration in gait and trunk tremor 
within one week in the second patient, 
who was admitted for observation and 
investigation while supplies of Penicilla-
mine were awaited, was strik,ing. The cli-
nical deterioration may be so rapid that 
the true diagnosis may not be suspected. 
Thus one of the original diagnoses in Case 
I was that of an acute encepha:Htis. 
The system used dn grading the deg-
ree of clinical neurological disturbance in 
Wi1lson's disease, by Goldstein, Randall, 
Gross, Rosevear and McGuckin (1962) 
should be more widely adopted by other 
workers in the ,field as i.t helps to standar-
dise the amDunt of clinical diisabiHty pre-
sent and the response to therapy. Gold-
stein and his colleagues propose five cate-
gories. Patients are classed as Grade 0, 
when no symptom or sign is noticeable to 
the patient; Grade 1, when there are mi-
ntmal hut definite signs or symptoms; 
Grade 2, ,when the si'gns are moderate but 
the patient is sWl aJble to work at his usual 
job; Grade 3, when there are severe sym-
ptoms Dr signs and the patient is unable 
to work at his job but is at least par.tly 
ruble to walk, write, dress and feed himself; 
Grade 4, - the most severe grade - with 
incapacitating symptoms, preventdng the 
pa:tient from walking, writing, dressing or 
feeding himself, ,and keeping the patient 
bedridden. This system of clinical assess-
ment is particularly useful in comparing 
the effects of therapy both in the same 
and ,in different series, and should yield 
over the years valuable information. It is 
suggested that this s,ubject of clinical clas-
sification with an extension to' deal with 
liver damage ShDUld be disoussed by the 
different authorities Dn Wilson's disease 
and that an international olassification be 
agreed upon. 
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